StatLab Acquires Histoserve GmbH and Remaining Stake in Diapath France SAS
August 13, 2025
StatLab Medical Products completed the acquisitions of Germany-based Histoserve GmbH and the remaining stake in Diapath France SAS, bringing both businesses into the Diapath/StatLab European organization. The transactions expand StatLab’s direct commercial presence across the four largest European pathology markets (France, Germany, Italy and the UK) and strengthen service, distribution and equipment capabilities for pathology laboratories in those markets.
- Buyers
- StatLab Medical Products, Diapath S.p.A (a StatLab company)
- Targets
- Histoserve GmbH, Diapath France SAS
- Sellers
- Wolfgang Jakobi, Jacques Hannaby
- Industry
- Medical Devices
- Location
- Lower Saxony, Germany
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
StatLab Medical Products Acquires CellPath Ltd.
June 8, 2022
Medical Devices
StatLab Medical Products, a portfolio company of Audax Private Equity and Linden Capital Partners, acquired UK-based CellPath Ltd., a manufacturer and supplier focused on the histology and cytology markets. The deal adds injection-molding manufacturing capabilities, proprietary products (including the CellNass archiving service), and an established European customer base to support StatLab's international growth.
-
StageBio Acquires TPL Path Labs
October 21, 2020
Healthcare Services
StageBio, a portfolio company of Ampersand Capital Partners, has acquired TPL Path Labs of Freiburg, Germany, expanding its GLP/GCLP-compliant preclinical and clinical histopathology and molecular pathology capabilities in Europe. The deal increases StageBio's global scale and ability to serve multinational biopharma, medical device and academic researchers by adding a German laboratory facility and staff.
-
Audax Private Equity and Linden Capital Partners Acquire StatLab Medical Products
January 12, 2021
Medical Devices
Audax Private Equity and Linden Capital Partners have acquired StatLab Medical Products, a McKinney, Texas-based manufacturer and distributor of histology, cytology and immunohistochemistry consumables, reagents, and equipment. The deal — a purchase from Cressey & Company LP — positions StatLab for accelerated organic growth and buy-and-build activity to expand its product suite and customer base.
-
StatLab Medical Products Acquires Poly Scientific R&D
March 26, 2024
Medical Devices
StatLab Medical Products has acquired Poly Scientific R&D, a Bay Shore, New York-based manufacturer of pathology stains, reagents and tissue controls. The deal adds tissue control slide manufacturing and other anatomic pathology consumables to StatLab’s portfolio, expanding its manufacturing capabilities and market presence.
-
Summit Partners Makes Growth Investment in Dreampath Diagnostics
July 14, 2025
Medical Devices
Summit Partners has made a growth equity investment in Dreampath Diagnostics to accelerate the company's global expansion, scale operations and expand its product portfolio in anatomical pathology lab automation. Dreampath, headquartered in Strasbourg, France, provides patented scanners, software and consumables for sample traceability and manages more than 250 million samples across over 500 labs; financial terms were not disclosed.
-
StatLab Medical Products Acquires Scientific Device Laboratory
April 25, 2024
Medical Devices
StatLab Medical Products, a McKinney, Texas-based manufacturer of medical diagnostic supplies, has acquired Scientific Device Laboratory (SDL), a Chicago-area maker of printed diagnostic slides and consumables for anatomic pathology and microbiology. The acquisition expands StatLab's microbiology capabilities, adds a U.S. R&D/manufacturing hub, and creates a dual-continent footprint for glass-slide manufacturing to better serve hospital, OEM and research customers.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.